New psychoactive substances (NPS) are a heterogeneous group of substances. They are
associated with a number of health and social harms on an individual and societal level …

Abstract Context: Synthetic cannabinoids (SCs) such as “Spice”,“K2”, etc. are widely
available via the internet despite increasing legal restrictions. Currently, the prevalence of …

Epidemiological evidence demonstrates that cannabis use is associated with an increased
risk of psychotic outcomes, and confirms a dose‐response relationship between the level of …

Indole and indazole synthetic cannabinoids (SCs) featuring l-valinate or l-tert-leucinate
pendant group have recently emerged as prevalent recreational drugs, and their use has …

Prospective epidemiological studies have consistently demonstrated that cannabis use is
associated with an increased subsequent risk of both psychotic symptoms and …

There is a growing use of novel psychoactive substances containing synthetic cannabinoids.
Synthetic cannabinoid products have effects similar to those of natural cannabis, yet, these …

As part of an increasing worldwide use of designer drugs, recent use of compounds
containing cathinones and synthetic cannabinoids is especially prevalent. Here, we …

Synthetic cannabinoids (SCs) are the largest group of compounds currently monitored in
Europe by the EU Early Warning System on new psychoactive substances. Emerging …

A decline in response rates in traditional household surveys, combined with increased
internet coverage and decreased research budgets, has resulted in increased attractiveness …

Cannabis is becoming increasingly present in our society. In recent years, the line between
the natural (cannabis) and the synthetic (synthetic cannabinoids), the recreational …